PASC Post Acute Sequelae of COVID 19
Conditions
Brief summary
The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Study Objectives: To assess whether Qi-Gong improves physiological function in individuals with PASC. To evaluate whether Qi-Gong enhances quality of life in individuals with PASC. Study Design: If a comparison group is included, researchers will compare Qi-Gong with standard care to assess its effectiveness. Participant Involvement: Practice Qi-Gong three times per week for three months. Record physiological data monthly.
Interventions
BEHAVIORALQI-GONG and control
QIGONG
Sponsors
POCHIWU
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
Experimental Group:QIGONG Control Group
Eligibility
Sex/Gender
ALL
Age
20 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* PASC * above 20 y/o
Exclusion criteria
* Those who cannot cooperate * Severe schizophrenia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pulmonary Function Test (Forced vital capacity) | From enrollment to the end of treatment at 12 weeks | FVC，over 80% is better |
| Pulmonary Function Test (FEV1) | From enrollment to the end of treatment at 12 weeks | FEV1，over 80% is better |
| Pulmonary Function Test (FVCFEV1) | From enrollment to the end of treatment at 12 weeks | FVCFEV1，over 80% is better |
| Heart rate variability | From enrollment to the end of treatment at 12 weeks | Low Frequency,40%-60% |
| Quality of Life(The short version of the World Health Organization Quality of Life ，WHOQOL-BREF) | From enrollment to the end of treatment at 12 weeks | WHOQOL-BREF 4 domains,and each one score is 4 - 20. more score more better |
Countries
Taiwan
Contacts
Primary ContactPo-Chi Wu
Outcome results
None listed